Imaging of high-risk plaque

Cardiology

Volumn 100, Issue 4, 2003, Pages 160-175

  Nemirovsky, Dmitry ^a,b  

^a MOUNT SINAI HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Coronary; Imaging; Plaque; Unstable; Vulnerable

Indexed keywords

CALCIUM; CONTRAST MEDIUM; FLUOROCARBON; GADOLINIUM; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANGIOCARDIOGRAPHY; ARTERY CALCIFICATION; ARTERY COMPLIANCE; ARTERY DIAMETER; ATHEROSCLEROTIC PLAQUE; CELL INFILTRATION; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY ANGIOSCOPY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; CORONARY RISK; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FOLLOW UP; HEMODYNAMICS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INFLAMMATORY CELL; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; NEAR INFRARED SPECTROSCOPY; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RUPTURE; THERMAL ANALYSIS; THERMOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VASCULAR NECROSIS; X RAY ANALYSIS;

CORONARY ARTERIOSCLEROSIS; CORONARY THROMBOSIS; CORONARY VESSELS; DIAGNOSTIC IMAGING; HUMANS; RISK; SENSITIVITY AND SPECIFICITY; SYNDROME;

EID: 0346308185     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074810     Document Type: Review

References (91)

1. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, Borrico S, Gorlin R, Fuster V: Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988;12:56-62.
2. Little WC, Constantinescu M, Applegate RJ, Kutcher MA, Burrows MT, Kahl FR, Santamore WP: Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 1988;78:1157-1166.
3. Fuster V, Fayad ZA, Badimon JJ: Acute coronary syndromes: Biology. Lancet 1999; 353(suppl 2):SII5-SII9.
4. Falk E, Shah PK, Fuster V: Coronary plaque disruption. Circulation 1995;92:657-671.
5. Libby P: Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-2850.
6. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM: Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275.
7. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J: Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993;69:377-381.
8. Pasterkamp G, Falk E, Woutman H, Borst C: Techniques characterizing the coronary atherosclerotic plaque: Influence on clinical decision making? J Am Coll Cardiol 2000;36:13-21.
9. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R: Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997; 336:1276-1282.
10. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P: Macrophage myeloperoxidase regulation by granulocyte-macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 2001;158:879-891.
11. Maseri A, Fuster V: Is there a vulnerable plaque? Circulation 2003;107:2068-2071.
12. Gertz SD, Roberts WC: Hemodynamic shear force in rupture of coronary arterial atherosclerotic plaques. Am J Cardiol 1990;66:1368-1372.
13. Rioufol G, Finet G, Ginon I, André-Fouet X, Rossi R, Vialle E, Desjoyaux E, Convert G, Huret JF, Tabib A: Multiple atherosclerotic plaque rupture in acute coronary syndrome: A three-vessel intravascular ultrasound study. Circulation 2002;106:804-808.
14. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW: Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000;343: 915-922.
15. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A: Widespread coronary inflammation in unstable angina. N Engl J Med 2002;347:5-12.
16. Goldschmidt-Clermont PJ, Kandzari DE, Sketch MH Jr, Phillips HR: Inflammation, platelets, and glycoprotein IIb/IIIa inhibitors. J Invasive Cardiol 2002;14(suppl E):18E-26E.
17. Davies MJ: Stability and instability: Two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 1996;94: 2013-2020.
18. Casscells W, Naghavi M, Willerson JT: Vulnerable atherosclerotic plaque: A multifocal disease. Circulation 2003;107:2072-2075.
19. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A: The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424.
20. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336: 973-979.
21. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-733.
22. Levin DC, Fallon JT: Significance of the angiographic morphology of localized coronary stenoses: Histopathologic correlations. Circulation 1982;66:316-320.
23. Ambrose JA, Hjemdahl-Monsen CE: Arteriographic anatomy and mechanisms of myocardial ischemia in unstable angina. J Am Coll Cardiol 1987;9:1397-1402.
24. Thieme T, Wernecke KD, Meyer R, Brandenstein E, Habedank D, Hinz A, Felix SB, Baumann G, Kleber FX: Angioscopic evaluation of atherosclerotic plaques: Validation by histomorphologic analysis and association with stable and unstable coronary syndromes. J Am Coll Cardiol 1996;28:1-6.
25. Uchida Y, Nakamura F, Tomaru T, Morita T, Oshima T, Sasaki T, Morizuki S, Hirose J: Prediction of acute coronary syndromes by percutaneous coronary angioscopy in patients with stable angina. Am Heart J 1995;130:195-203.
26. Fayad ZA, Fuster V: Clinical imaging of the high-risk or vulnerable atherosclerotic plaque. Circ Res 2001;89:305-316.
27. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-1375.
28. Schoenhagen P, Nissen S: Understanding coronary artery disease: Tomographic imaging with intravascular ultrasound. Heart 2002;88:91-96.
29. Losordo DW, Rosenfield K, Kaufman J, Pieczek A, Isner JM: Focal compensatory enlargement of human arteries in response to progressive atherosclerosis: In vivo documentation using intravascular ultrasound. Circulation 1994; 89:2570-2577.
30. Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM: Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: An intravascular ultrasound study. Circulation 2000;101:598-603.
31. Takano M, Mizuno K, Okamatsu K, Yokoyama S, Ohba T, Sakai S: Mechanical and structural characteristics of vulnerable plaques: Analysis by coronary angioscopy and intravascular ultrasound. J Am Coll Cardiol 2001;38: 99-104.
32. Yamagishi M, Terashima M, Awano K, Kijima M, Nakatani S, Daikoku S, Ito K, Yasumura Y, Miyatake K: Morphology of vulnerable coronary plaque: Insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol 2000;35:106-111.
33. Kotani J, Castagna M, Pinnow E, Chalak B, Bui A, Pichard A, Satler L, Suddath W, Waksman R, Laird J, Kent K, Weissman N: Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction. Circulation 2003;107:2889-2893.
34. Yeung AC, Davis SF, Hauptman PJ, Kobashigawa JA, Miller LW, Valantine HA, Ventura HO, Wiedermann J, Wilensky R: Incidence and progression of transplant coronary artery disease over 1 year: Results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group. J Heart Lung Transplant 1995; 14(6 Pt 2):S215-S220.
35. Nissen SE, Yock P: Intravascular ultrasound: Novel pathophysiological insights and current clinical applications. Circulation 2001;103: 604-616.
36. Gradus-Pizlo I, Sawada SG, Wright D, Segar DS, Feigenbaum H: Detection of subclinical coronary atherosclerosis using two-dimensional, high-resolution transthoracic echocardiography. J Am Coll Cardiol 2001;37:1422-1429.
37. Brezinski ME, Tearney GJ, Weissman NJ, Boppart SA, Bouma BE, Hee MR, Weyman AE, Swanson EA, Southern JF, Fujimoto JG: Assessing atherosclerotic plaque morphology: Comparison of optical coherence tomography and high frequency intravascular ultrasound. Heart 1997;77:397-403.
38. Brezinski ME, Tearney GJ, Bouma BE, Izatt JA, Hee MR, Swanson EA, Southern JF, Fujimoto JG: Optical coherence tomography for optical biopsy: Properties and demonstration of vascular pathology. Circulation 1996;93: 1206-1213.
39. Jang IK, Bouma BE, Kang DH, Park SJ, Park SW, Seung KB, Choi KB, Shishkov M, Schlendorf K, Pomerantsev E, Houser SL, Aretz HT, Tearney GJ: Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: Comparison with intravascular ultrasound. J Am Coll Cardiol 2002; 39:604-609.
40. Moreno PR, Muller JE: Identification of high-risk atherosclerotic plaques: A survey of spectroscopic methods. Curr Opin Cardiol 2002; 17:638-647.
41. Moreno PR, Lodder RA, Purushothaman KR, Charash WE, O'Connor WN, Muller JE: Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy. Circulation 2002;105:923-927.
42. Chen J, Tung CH, Mahmood U, Ntziachristos V, Gyurko R, Fishman MC, Huang PL, Weissleder R: In vivo imaging of proteolytic activity in atherosclerosis. Circulation 2002;105:2766-2771.
43. Khan T, Madjid M, Casscells W, Naghavi M: Visible/near-infrared optical catheter prototype accurately determines pH and lactate of atherosclerotic plaques; in: Imaging and Vulnerable Plaque. TCT 2002 [abstract].
44. Schmermund A, Mohlenkamp S, Erbel R: The latest on the calcium story. Am J Cardiol 2002; 90:12L-14L.
45. Budoff MJ, Georgiou D, Brody A, Agatston AS, Kennedy J, Wolfkiel C, Stanford W, Shields P, Lewis RJ, Janowitz WR, Rich S, Brundage BH: Ultrafast computed tomography as a diagnostic modality in the detection of coronary artery disease: A multicenter study. Circulation 1996;93:898-904.
46. Mautner GC, Mautner SL, Froehlich J, Feuerstein IM, Proschan MA, Roberts WC, Doppman JL: Coronary artery calcification: Assessment with electron beam CT and histomorphometric correlation. Radiology 1994;192: 619-623.
47. Burke AP, Kolodgie FD, Farb A, Weber D, Virmani R: Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation 2002;105:297-303.
48. Redberg RF, Vogel RA, Criqui M, Herrington D, Lima J, Roman M: 34th Bethesda Conference: Task force #3 - What is the spectrum of current and emerging techniques for the noninvasive measurement of atherosclerosis. J Am Coll Cardiol 2003;41:1886-1898.
49. Nallamothu BK, Saint S, Bielak LF, Sonnad SS, Peyser PA, Rubenfire M, Fendrick AM: Electronbeam computed tomography in the diagnosis of coronary artery disease: A meta-analysis. Arch Intern Med 2001;161:833-838.
50. O'Malley PG, Taylor AJ, Jackson JL, Doherty TM, Detrano RC: Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations. Am J Cardiol 2000;85:945-948.
51. O'Rourke RA, Brundage BH, Froelicher VF, Greenland P, Grundy SM, Hachamovitch R, Pohost GM, Shaw LJ, Weintraub WS, Winters WL Jr: American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol 2000;36:326-340.
52. Arad Y, Newstein D, Guerci A: Coronary calcification, coronary disease risk factors, and atherosclerotic cardiovascular events: The St. Francis Heart Study; in: American College of Cardiology Scientific Sessions 2003. Chicago 2003.
53. Kondos G, Hoff J, Sevrukov A, Daviglus M, Garside D, Devries S, Chomka E, Liu K: Electron-beam tomography coronary artery calcium and cardiac events. Circulation 2003; 107:2571-2576.
54. Park R, Detrano R, Xiang M, Fu P, Ibrahim Y, LaBree L, Azen S: Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals. Circulation 2002;106:2073-2077.
55. Wexler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddahi J, Rumberger J, Stanford W, White R, Taubert K: Coronary artery calcification: Pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association Writing Group. Circulation 1996;94:1175-1192.
56. Schmermund A, Erbel R: Unstable coronary plaque and its relation to coronary calcium. Circulation 2001;104:1682-1687.
57. Lee TC, O'Malley PG, Feuerstein I, Taylor AJ: The prevalence and severity of coronary artery calcification on coronary artery computed tomography in black and white subjects. J Am Coll Cardiol 2003;41:39-44.
58. Budoff MJ, Oudiz RJ, Zalace CP, Bakhsheshi H, Goldberg SL, French WJ, Rami TG, Brundage BH: Intravenous three-dimensional coronary angiography using contrast-enhanced electron-beam computed tomography. Am J Cardiol 1999;83:840-845.
59. Achenbach S, Moshage W, Ropers D, Nossen J, Daniel WG: Value of electron-beam computed tomography for the noninvasive detection of high-grade coronary artery stenoses and occlusions. N Engl J Med 1998;339:1964-1971.
60. Zarrabi AD, Dong Z, Cohen A, Litovsky S, Madjid M, Casscells W, Willerson JT, Naghavi M: A Novel liposomal encapsulated iohexol (Omnipaque) for detection of inflammation by computed tomography: A potential method for identification of vulnerable plaques; in: Imaging and Vulnerable Plaque. TCT 2002 [abstract].
61. Fayad ZA, Fuster V, Nikolaou K, Becker C: Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: Current and potential future concepts. Circulation 2002;106: 2026-2034.
62. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL: Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996;94:932-938.
63. Hatsukami TS, Ross R, Polissar NL, Yuan C: Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation 2000;102:959-964.
64. Fayad ZA, Nahar T, Fallon JT, Goldman M, Aguinaldo JG, Badimon JJ, Shinnar M, Chesebro JH, Fuster V: In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: A comparison with trans-esophageal echocardiography. Circulation 2000;101:2503-2509.
65. Johnstone MT, Botnar RM, Perez AS, Stewart R, Quist WC, Hamilton JA, Manning WJ: In vivo magnetic resonance imaging of experimental thrombosis in a rabbit model. Arterioscler Thromb Vasc Biol 2001;21:1556-1560.
66. Fayad ZA, Fuster V, Fallon JT, Jayasundera T, Worthley SG, Helft G, Aguinaldo JG, Badimon JJ, Sharma SK: Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation 2000;102:506-510.
67. Worthley SG, Helft G, Fuster V, Zaman AG, Fayad ZA, Fallon JT, Badimon JJ: Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. Circulation 2000;101:586-589.
68. Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J, Mercuri M, Badimon JJ: Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: A longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 2001;104: 249-252.
69. Helft G, Worthley SG, Fuster V, Fayad ZA, Zaman AG, Corti R, Fallon JT, Badimon JJ: Progression and regression of atherosclerotic lesions: Monitoring with serial noninvasive magnetic resonance imaging. Circulation 2002; 105:993-998.
70. Zhao XQ, Yuan C, Hatsukami TS, Frechette EH, Kang XJ, Maravilla KR, Brown BG: Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: A case-control study. Arterioscler Thromb Vasc Biol 2001;21: 1623-1629.
71. Yuan C, Kerwin WS, Ferguson MS, Polissar N, Zhang S, Cai J, Hatsukami TS: Contrast-enhanced high-resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 2002;15:62-67.
72. Flacke S, Fischer S, Scott MJ, Fuhrhop RJ, Allen JS, McLean M, Winter P, Sicard GA, Gaffney PJ, Wickline SA, Lanza GM: Novel MRI contrast agent for molecular imaging of fibrin: Implications for detecting vulnerable plaques. Circulation 2001;104:1280-1285.
73. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF: Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001;103:415-422.
74. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M, Frederik PM, Daemen MJ, van Engelshoven JM: Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003;107:2453-2438.
75. Choudhury RP, Fuster V, Badimon JJ, Fisher EA, Fayad ZA: MRI and characterization of atherosclerotic plaque: Emerging applications and molecular imaging. Arterioscler Thromb Vasc Biol 2002;22:1065-1074.
76. Worthley SG, Helft G, Fuster V, Fayad ZA, Rodriguez OJ, Zaman AG, Fallon JT, Badimon JJ: Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model. Circulation 2000; 101:2956-2961.
77. Fayad ZA, Fuster V: The human high-risk plaque and its detection by magnetic resonance imaging. Am J Cardiol 2001;88:42E-45E.
78. Botnar RM, Kim WY, Bornert P, Stuber M, Spuentrup E, Manning WJ: 3D coronary vessel wall imaging utilizing a local inversion technique with spiral image acquisition. Magn Reson Med 2001;46:848-854.
79. Botnar RM, Stuber M, Kissinger KV, Manning WJ: Free-breathing 3D coronary MRA: The impact of 'isotropic' image resolution. J Magn Reson Imaging 2000;11:389-393.
80. Kim WY, Danias PG, Stuber M, Flamm SD, Plein S, Nagel E, Langerak SE, Weber OM, Pedersen EM, Schmidt M, Botnar RM, Manning WJ: Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001;345:1863-1869.
81. Zarrabi A, Gul K, Willerson JT, Casscells W, Naghavi M: Intravascular thermography: A novel approach for detection of vulnerable plaque. Curr Opin Cardiol 2002;17:656-662.
82. Casscells W, Hathorn B, David M, Krabach T, Vaughn WK, McAllister HA, Bearman G, Willerson JT: Thermal detection of cellular infiltrates in living atherosclerotic plaques: Possible implications for plaque rupture and thrombosis. Lancet 1996;347:1447-1451.
83. Naghavi M, John R, Naguib S, Siadaty MS, Grasu R, Kurian KC, van Winkle WB, Soller B, Litovsky S, Madjid M, Willerson JT, Casscells W: pH heterogeneity of human and rabbit atherosclerotic plaques: A new insight into detection of vulnerable plaque. Atherosclerosis 2002;164:27-35.
84. Stefanadis C, Diamantopoulos L, Vlachopoulos C, Tsiamis E, Dernellis J, Toutouzas K, Stefanadi E, Toutouzas P: Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter. Circulation 1999;99:1965-1971.
85. Stefanadis C, Diamantopoulos L, Dernellis J, Economou E, Tsiamis E, Toutouzas K, Vlachopoulos C, Toutouzas P: Heat production of atherosclerotic plaques and inflammation assessed by the acute-phase proteins in acute coronary syndromes. J Mol Cell Cardiol 2000;32:43-52.
86. Madjid M, Naghavi M, Malik BA, Litovsky S, Willerson JT, Casscells W: Thermal detection of vulnerable plaque. Am J Cardiol 2002;90: 36L-39L.
87. Stefanadis C, Toutouzas K, Tsiamis E, Stratos C, Vavuranakis M, Kallikazaros I, Panagiotakos D, Toutouzas P: Increased local temperature in human coronary atherosclerotic plaques: An independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention. J Am Coll Cardiol 2001; 37:1277-1283.
88. Stefanadis C, Toutouzas K, Vavuranakis M, Tsiamis E, Tousoulis D, Panagiotakos DB, Vaina S, Pitsavos C, Toutouzas P: Statin treatment is associated with reduced thermal heterogeneity in human atherosclerotic plaques. Eur Heart J 2002;23:1664-1669.
89. Tsimikas S: Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies. Am J Cardiol 2002;90:22L-27L.
90. Lindner JR: Detection of inflamed plaques with contrast ultrasound. Am J Cardiol 2002; 90:32L-35L.
91. Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, Johnstrom P, Davenport AP, Kirkpatrick PJ, Arch BN, Pickard JD, Weissberg PL: Imaging atherosclerotic plaque inflammation with [(18)F]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708-2711.